Assessment of lacrimal glands in thyroid eye disease with diffusion-weighted magnetic resonance imaging
- PMID: 31019608
- PMCID: PMC6479144
- DOI: 10.5114/pjr.2019.84096
Assessment of lacrimal glands in thyroid eye disease with diffusion-weighted magnetic resonance imaging
Abstract
Purpose: To assess the lacrimal glands in patients with thyroid eye disease with diffusion-weighted magnetic resonance (MR) imaging.
Material and methods: This study was carried out on 44 consecutive patients (17 males, 27 females, with mean age 36 years) with thyroid eye disease and 20 age- and sex-matched volunteers. They underwent diffusion-weighted MR imaging of the orbit. The apparent diffusion coefficient (ADC) values of the lacrimal glands were calculated and correlated with the clinical activity score (CAS).
Results: The mean ADC of lacrimal glands in thyroid eye disease (1.73 × 10-3 mm2/s) was significantly higher (p = 0.001) than that of volunteers (1.52 × 10-3 mm2/s). The cutoff ADC value of lacrimal gland used for differentiation of thyroid eye disease from volunteers was 1.62 × 10-3 mm2/s with an area under the curve value of 0.95 and an accuracy of 96%. There was significant difference (p = 0.03) in the ADC of the lacrimal glands in patients with active (n = 24) and inactive (n = 20) disease. The cutoff ADC value of the lacrimal gland used to suspect active disease was 1.76 × 10-3 mm2/s with an area under the curve value of 0.80 and an accuracy of 82%. There was positive correlation between the ADC value of the lacrimal glands and CAS (r = 0.73, p = 0.001).
Conclusions: The ADC of the lacrimal glands is a non-invasive imaging parameter that can be used for diagnosis of thyroid eye disease and to predict the active form of the disease.
Keywords: MR imaging; diffusion; lacrimal gland; thyroid eye disease.
Conflict of interest statement
The authors report no conflict of interest.
Figures


Similar articles
-
Magnetic resonance imaging parameters on lacrimal gland in thyroid eye disease: a systematic review and meta-analysis.BMC Ophthalmol. 2023 Aug 8;23(1):347. doi: 10.1186/s12886-023-03008-x. BMC Ophthalmol. 2023. PMID: 37550660 Free PMC article.
-
[Value of the apparent diffusion coefficient in diffusion weighted imaging at 3.0T MR for differentiating lacrimal gland tumors].Zhonghua Yi Xue Za Zhi. 2019 Jan 1;99(1):53-56. doi: 10.3760/cma.j.issn.0376-2491.2019.01.012. Zhonghua Yi Xue Za Zhi. 2019. PMID: 30641666 Chinese.
-
Diffusion-weighed MR of the thyroid gland in Graves' disease: assessment of disease activity and prediction of outcome.Acad Radiol. 2010 Jun;17(6):779-83. doi: 10.1016/j.acra.2010.01.014. Epub 2010 Mar 28. Acad Radiol. 2010. PMID: 20350826
-
Role of Diffusion-Weighted Magnetic Resonance (MR) Imaging in Differentiation Between Graves' Disease and Painless Thyroiditis.Pol J Radiol. 2017 Sep 15;82:536-541. doi: 10.12659/PJR.902416. eCollection 2017. Pol J Radiol. 2017. PMID: 29662585 Free PMC article.
-
Apparent diffusion coefficient measurement of the parotid gland parenchyma.Quant Imaging Med Surg. 2021 Aug;11(8):3812-3829. doi: 10.21037/qims-20-1178. Quant Imaging Med Surg. 2021. PMID: 34341752 Free PMC article. Review.
Cited by
-
Histopathological features of asymmetric lacrimal gland enlargement in patients with thyroid eye disease.Thyroid Res. 2023 Aug 14;16(1):32. doi: 10.1186/s13044-023-00174-4. Thyroid Res. 2023. PMID: 37580720 Free PMC article.
-
Magnetic resonance imaging parameters on lacrimal gland in thyroid eye disease: a systematic review and meta-analysis.BMC Ophthalmol. 2023 Aug 8;23(1):347. doi: 10.1186/s12886-023-03008-x. BMC Ophthalmol. 2023. PMID: 37550660 Free PMC article.
-
Apparent diffusion coefficient: a predictor of the efficacy of glucocorticoid therapy in active moderate-severe thyroid eye disease: a retrospective cohort study.BMC Endocr Disord. 2025 Jul 14;25(1):177. doi: 10.1186/s12902-025-01981-6. BMC Endocr Disord. 2025. PMID: 40660145 Free PMC article.
-
Computed tomography and magnetic resonance imaging approaches to Graves' ophthalmopathy: a narrative review.Front Endocrinol (Lausanne). 2024 Jan 8;14:1277961. doi: 10.3389/fendo.2023.1277961. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38260158 Free PMC article. Review.
-
Beyond dry eye: how co-morbidities influence disease phenotype in dry eye disease.Clin Exp Optom. 2022 Mar;105(2):177-185. doi: 10.1080/08164622.2021.1962210. Epub 2021 Aug 8. Clin Exp Optom. 2022. PMID: 34369296 Free PMC article. Review.
References
-
- Weiler DL. Thyroid eye disease: a review. Clin Exp Optom. 2017;100:20–25. - PubMed
-
- Smith TJ, Hegedüs L. Graves’ disease. N Engl J Med. 2016;375:1552–1555. - PubMed
-
- Byun JS, Moon NJ, Lee JK. Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy. Graefes Arch Clin Exp Ophthalmol. 2017;255:413–420. - PubMed
LinkOut - more resources
Full Text Sources